InsiderTrades

Form 4 for GH Guardant Health, Inc.

Accepted 2022-08-15 00:00:00 ET · period of report 2022-08-11 · accession 0001576280-22-000067 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-08-15 2022-08-11+ GH Merrill Amelia SVP, People S - Sale+OE $53.85 -9,000 20.2K -31% -$484.6K
D 2022-08-15 2022-08-11 GH Merrill Amelia SVP, People M - OptEx $4.18 +5,000 29.2K +21% +$20.9K
D 2022-08-15 2022-08-11 GH Merrill Amelia SVP, People M - OptEx $4.18 -5,000 33.7K -13% -$20.9K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common COMMON STOCK 2022-08-11 S D 4,500 $53.38 24,708 D — — (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $53.32 to $53.53, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
2 Common COMMON STOCK 2022-08-12 S D 4,500 $54.32 20,208 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $54.16 to $54.465, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
3 Common COMMON STOCK 2022-08-11 M A 5,000 $4.18 29,208 D — —
4 Derivative STOCK OPTION (RIGHT TO BUY) 2022-08-11 M D 5,000 $4.18 33,735 D $4.18 · — to 2027-05-31 5,000 COMMON STOCK (F3) The stock option vests and becomes exercisable as to 25% of the shares on May 1, 2018, and then in equal monthly installments through May 1, 2021.